Melperone
| Clinical data | |
|---|---|
| Trade names | Buronil | 
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration | Oral, intramuscular injection | 
| ATC code | |
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Bioavailability | 87% (IM), 54% (Oral via syrup), 65% (Oral, tablet) | 
| Protein binding | 50% | 
| Metabolism | Hepatic | 
| Elimination half-life | 3–4 hours (oral) 6 hours (IM) | 
| Excretion | Renal (70% as metabolites, 5.5–10.4% as unchanged drug) | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.107.027 | 
| Chemical and physical data | |
| Formula | C16H22FNO | 
| Molar mass | 263.356 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (verify) | |
Melperone (Bunil (PT), Buronil (AT, BE, CZ, DK, FI†, NL†, NO†, SE), Eunerpan (DE)) is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. It first entered clinical use in 1960s.